📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

Innospec Upgraded To Strong Buy On Robust Q1 And Prospects

Published 06/15/2017, 02:56 AM
Updated 07/09/2023, 06:31 AM
SHW
-
IOSP
-
HUN
-
CC
-

Chemical maker Innospec Inc. (NASDAQ:IOSP) was upgraded to a Zacks Rank #1 (Strong Buy) on Jun 15. Going by the Zacks model, companies carrying a Zacks Rank #1 have higher chances of outperforming the broader market.

Why the Upgrade?

Innospec has an impressive earnings surprise history. The company has outpaced the Zacks Consensus Estimate in three of the trailing four quarters, delivering a positive average earnings surprise of 8.07%.

In the first-quarter 2017, Innospec posted better-than-expected results. The company posted adjusted earnings of $1.00 per share, exceeding the Zacks Consensus Estimate of 95 cents.

Revenues for the quarter rose about 39% year over year to $294.3 million, on the back of higher sales volume across core business segments. Sales from the Oilfield Services division surged roughly 84% year over year to $66.5 million, while Performance Chemicals unit expanded nearly three-fold to $94.5 million. The Octane Additives segment also demonstrated a stellar performance by recording roughly 61% year-over-year growth to $6.9 million.

Innospec Inc. Price and Consensus

Innospec Inc. Price and Consensus | Innospec Inc. Quote

The company is well positioned to record strong growth in all its business segments moving ahead. Innospec continues to integrate its recent acquisitions and is also pursuing other strategic buyouts to boost its portfolio.

Innospec also hiked its semi-annual dividend by 15% to 38 cents per common share for first-half 2017.

Innospec’s shares have moved up 8.4% in the last three months, outperforming the Zacks categorized Chemicals-Diversified industry’s gain of 3.7%.



Other Stocks to Consider

Other top-ranked companies in the basic materials space include The Sherwin-Williams Company (NYSE:SHW) , The Chemours Company (NYSE:CC) and Huntsman Corporation (NYSE:HUN) . All the three stocks sport a Zacks Rank #1. You can see the complete list of today’s Zacks Rank #1 stocks here.

Sherwin-Williams has expected long-term earnings growth rate of 11.4%.

Chemours has expected long-term earnings growth rate of 15.5%.

Huntsman has expected long-term earnings growth rate of 7%.

3 Stocks to Ride a 588% Revenue Explosion

At Zacks, we're mostly focused on short-term profit cycles, but the hottest of all technology mega-trends is starting to take hold...

By last year, it was already generating $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for those who make the right trades early. See Zacks' Top 3 Stocks to Ride This Space >>



Huntsman Corporation (HUN): Free Stock Analysis Report

Chemours Company (The) (CC): Free Stock Analysis Report

Innospec Inc. (IOSP): Free Stock Analysis Report

Sherwin-Williams Company (The) (SHW): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.